Malfertheiner, P.; Versage, E.; Twuijver, E.V.; Rizzardini, G.; Hohenboken, M.
Safety, Tolerability, and Immunogenicity of aH5N1 Vaccine in Adults with and Without Underlying Immunosuppressive Conditions. Vaccines 2025, 13, 379.
https://doi.org/10.3390/vaccines13040379
AMA Style
Malfertheiner P, Versage E, Twuijver EV, Rizzardini G, Hohenboken M.
Safety, Tolerability, and Immunogenicity of aH5N1 Vaccine in Adults with and Without Underlying Immunosuppressive Conditions. Vaccines. 2025; 13(4):379.
https://doi.org/10.3390/vaccines13040379
Chicago/Turabian Style
Malfertheiner, Peter, Eve Versage, Esther Van Twuijver, Giuliano Rizzardini, and Matthew Hohenboken.
2025. "Safety, Tolerability, and Immunogenicity of aH5N1 Vaccine in Adults with and Without Underlying Immunosuppressive Conditions" Vaccines 13, no. 4: 379.
https://doi.org/10.3390/vaccines13040379
APA Style
Malfertheiner, P., Versage, E., Twuijver, E. V., Rizzardini, G., & Hohenboken, M.
(2025). Safety, Tolerability, and Immunogenicity of aH5N1 Vaccine in Adults with and Without Underlying Immunosuppressive Conditions. Vaccines, 13(4), 379.
https://doi.org/10.3390/vaccines13040379